化合物 Peldesine dihydrochloride T60799

Product Introduction
Bioactivity


英文名: Peldesine dihydrochloride

描述: Peldesine (BCX 34) dihydrochloride 是一种有效的，竞争性，可逆和口服活性的嘌呤核苷磷酸化酶 (PNP) 抑制剂，对人，大鼠和小鼠红细胞 (RBC)PNP 的 IC50分别为 36 nM，5 nM 和 32 nM。Peldesine dihydrochloride 还是一种 T 细胞 (T-cell) 增殖抑制剂，IC50为 800 nM。Peldesine dihydrochloride 可用于皮肤 T 细胞淋巴瘤，牛皮癣和 HIV 感染的研究。

体外活性: Peldesine (BCX 34; 0-50 μM; 72 hours; Jurkat cells) could inhibit the T-cell proliferation completely at a concentration of less than 10 μM, in the presence of dGuo (10 μM). In contrast, the B-cell proliferation is not affected by Peldesine [1]. Peldesine (BCX 34) suppresses T-cell immune reaction in an IL-2-independent manner, and this means that Peldesine might affect a late phase rather than an early stage in T-cell activation [1]. Peldesine also, in the presence but not in the absence of deoxyguanosine, inhibits human leukemia CCRF-CEM T-cell proliferation with an IC 50 of 0.57 μM but not rat or mouse T-cell proliferation up to 30 μM [3]. Cell Viability Assay [1] Cell Line: Jurkat cells Concentration: 0-50 μM Incubation Time: 72 hours Result: In the presence of 10 μM dCuo, had a complete inhibitory effect for T-cell lines.

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

化合物 Peldesine dihydrochloride T60799信息由TargetMol中国为您提供，如您想了解更多关于化合物 Peldesine dihydrochloride T60799报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途